Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTAP101 in CKD, Vitamin D Insufficiency and SHPT
NCT01219855Phase 3Completed
- Sponsor
- OPKO Health
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of calcifediol in secondary hyperparathyroidism (SHPT), Vitamin D deficiency (VDD), sponsored by OPKO Health. Started Oct 2010; status: completed.
02
Drugs
calcifediol
03
Conditions
secondary hyperparathyroidism (SHPT)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01219855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219855.